Sustained Release Excipients Market Size, Share Report, 2031

Posted by pooja on August 4th, 2022

The demand within the global sustained release excipients market has been rising on account of key improvements in the pharmaceutical industry. Sustained dosing of drugs holds immense significance for a range of industries, and hence, the use of sustained release excipients has become more pronounced in recent times. Excipients for modified release help in releasing drugs at a slow pace over an extended time period, and this helps in avoiding dose-dumping. 

The global sustained release excipients market is projected to keep expanding over the forthcoming years. This projection is based on the expansive developments that have offset in the pharmaceutical industry over the past decade. The ability of sustained drug release to relieve patients of pain has created tremendous demand within the global market for sustained release excipients in recent times. Furthermore, the advantages served by sustained drug release over conventional drugs are also expected to give an impetus to the growth of the global sustained release excipients market.

Some of the key players in the global sustained release excipients market are Depomed, Inc.; Capsugel; Aradigm Corporation; Corium International, Inc.; and Orbis Biosciences, Inc.

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to busi-ness entities keen on succeeding in today’s supercharged economic climate. Armed with an experi-enced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Rohit Bhisey
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Visit Site:

Like it? Share it!


About the Author

Joined: July 27th, 2022
Articles Posted: 199

More by this author